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Abstract
The fungal metabolite (+)-11,11'-dideoxyverticillin A, a cytotoxic alkaloid isolated from a marine 
Penicillium sp., belongs to a fascinating family of densely functionalized, stereochemically 
complex, and intricate dimeric epidithiodiketopiperazine natural products. Although the dimeric 
epidithiodiketopiperazines have been known for nearly four decades, none has succumbed to total 
synthesis. We report a concise enantioselective total synthesis of (+)-11,11'-dideoxyverticillin A 
via a strategy inspired by our biosynthetic hypothesis for this alkaloid. Highly stereo- and 
chemoselective advanced stage tetrahydroxylation and tetrathiolation reactions, as well as a mild 
strategy for the introduction of the epidithiodiketopiperazine core in the final step were developed 
to address this highly sensitive substructure. Our rapid functionalization of the advanced 
molecular framework aims to mimic plausible biosynthetic steps and offers an effective strategy 
for the chemical synthesis of other members of this family of alkaloids.
The fungal metabolite (+)-11,11'- dideoxyverticillin A (1, Fig. 1) (1) is a member of the 
epidithiodiketopiperazine alkaloids, a large family of natural products that has received 
significant attention from the scientific community for its rich biological activity and 
complex molecular architecture (2–7). The dimeric subset of alkaloids to which the title 
compound belongs has been known for nearly four decades with the isolation of (+)-
chaetocin A (2, 8) and (+)-verticillin A (3, 9). Reflective of the daunting challenges posed 
by molecular structures replete with sterically congested stereogenic centers, and highly 
acid-, base-, and redoxsensitive functional groupings (5), no dimeric 
epidithiodiketopiperazine alkaloid has yet succumbed to total synthesis. Herein we describe 
a concise strategy for the enantioselective total synthesis of the dimeric 
epidithiodiketopiperazine alkaloid (+)-1. Our biosynthetically inspired synthesis features 
stereo- and chemoselective advanced stage tetrahydroxylation and tetrathiolation reactions, 
providing a generalizable solution to the epidithiodiketopiperazine substructure found in the 
broader family of these alkaloids.
At the outset of our synthetic studies, structural similarities among members of the alkaloid 
family combined with related feeding experiments and biosynthetic hypotheses by Kirby 
(10) prompted us to consider the possibility that the epidisulfides are assembled by enzymes 
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that exploit the inherent chemistry of dimeric diketopiperazines. Our retrosynthetic analysis 
of (+)-1 imitates a plausible biosynthetic sequence of events linking dimeric 
epidithiodiketopiperazines to common α-amino acid precursors (Fig. 2). We envisioned 
preparation of (+)-1 by mild oxidation of the tetrathiol 5, which could be accessed via 
stereoselective tetrathiolation of an octacyclic tetraol 6. In contrast to a previous biosynthetic 
hypothesis for monomeric epidithiodiketopiperazines invoking thiolation via an N-
hydroxylation– dehydration sequence (11), we speculated that a post-dimerization Cα-
hydroxylation would enable substrate directed hemiaminal thiolation through the 
intermediacy of an acyliminium ion. Intermediate 7, which we hypothesized to arise from a 
dimerization event, could be assembled from the readily available cyclo-dipeptide 8 using 
the concise cobalt-mediated dimerization strategy reported from our laboratories (12–13). 
The imposing challenges associated with quadruple Cα-methine hydroxylation of 7 and the 
tetrathiolation of intermediate 6 notwithstanding, the need for absolute and relative 
stereochemical control (Fig. 2) of the six tetrasubstituted carbons of (+)-1 posed noteworthy 
strategic concerns. We envisioned the introduction of C3 and C3' vicinal quaternary 
stereocenters as a prelude to stereochemical control of the four thiolated– carbon stereogenic 
centers of (+)-1. Such a final stage tetrathiolation followed by immediate disulfide formation 
would obviate the need to mask the notoriously sensitive epidithiodiketopiperazine 
functional grouping in the early stages of the synthesis.
The dimeric diketopiperazine (+)-13 was assembled in six steps from commercially 
available amino acid derivatives (Fig. 3) (14). The sequential treatment of amide (–)-9 with 
trifluoroacetic acid followed by cyclization with morpholine readily afforded access to the 
desired cis-diketopiperazine (–)-10 in 84% yield (>20g). Exposure of cyclo-Ltryptophan-L-
alanine (–)-10 to molecular bromine in acetonitrile at 0 °C furnished the desired monomeric 
tetracyclic bromide (+)-11 in 76% isolated yield (14). Treatment of tetracyclic bromide 
(+)-11 with methyl iodide and potassium carbonate gave the base-sensitive dimerization 
precursor (+)-12 in 77% yield (15). Reductive dimerization of the tertiary benzylic bromide 
(+)-12 with tris(triphenylphosphine)cobalt(I) chloride in acetone provided the key dimeric 
octacyclic intermediate (+)-13 in 46% yield (16). Preference for cis-fusion on 5,5-ring 
systems made this an effective strategy for simultaneously securing the two vicinal C3 and 
C3' quaternary stereocenters (12). This chemistry is amenable to multi-gram scale synthesis 
of (+)-13 (e.g., 43% yield on 8g-scale).
Guided by our biosynthetic hypothesis for late stage functionalization of the 
diketopiperazines (i.e., 7→5, Fig. 2), we sought methods for Cα-oxidation of the dimeric 
octacycle (+)-13. Initially, we focused on the oxidation of the readily accessible enol 
tautomers or corresponding enolates of (+)-13 (14). Unfortunately, these strategies were 
plagued by formation of partially oxidized and diastereomeric products in addition to 
significant competing decomposition. Likewise, a variety of softenolization and electrophilic 
amide activation strategies failed to provide the necessary Cα-methine oxidation. Although 
we ultimately developed conditions for dihydroxylation (or didehydrogenation) of a model 
monomeric tetracyclic diketopiperazine 21 (Fig. 4A) along with its conversion to the 
corresponding monomeric epidithiodiketopiperazine 23 (14), none of these methodologies 
proved effective when applied to the more challenging dimeric octacyclic 
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bisdiketopiperazine (+)-13, likely due to additional modes of C3-C3' bond fragmentation 
and/or unfavorable interactions between the tetracyclic subunits.
Careful analysis of the bond dissociation energies (17) involved in our successful radical 
based abstraction of Cα-methines in the model tetracycle 21 (14) suggested weak Cα–H 
bonds due to stabilization of the ensuing Cα-radicals in diketopiperazines. Thus, the use of 
mild oxidants typically reserved for hydrogen atom abstraction from formyl groups became 
a focus of our efforts in pursuit of an effective strategy for single-step tetrahydroxylation of 
dimeric octacycle (+)-13. After extensive experimentation, we discovered that the treatment 
of the diketopiperazine 21 with tetra-n-butylammonium permanganate (3.0 equiv) (18) in 
pyridine at 23 °C for 2 h provided the desired tetracyclic diol 22 in 78% yield primarily as 
one diastereomer. Application of these conditions to the oxidation of the more challenging 
dimeric octacycle (+)-13 resulted in 40% yield of the desired tetraol as a complex mixture of 
hemiaminal diastereomers. As this tetrahydroxylation was fraught with competing 
epimerization of Cα-methines and incomplete oxidation leading to complex product 
mixtures (14), we sought to refine this reaction.
Further studies revealed that bis(pyridine)-silver(I) permanganate (Py2AgMnO4) (19) 
oxidized dimeric octacycle (+)-13 selectively and efficiently. Under optimal conditions, 
treatment of dimer (+)-13 with Py2AgMnO4 (4.8 equiv) in dichloromethane at 23 °C for 2 h 
afforded the desired dimeric octacyclic tetraol (+)-14 in 63% yield as a single diastereomer 
(Fig. 3). The high level of diastereoselection (14) is consistent with a fast abstraction-
rebound mechanism (20–21), as suggested by hydroxylation of the radical– clock hydantoin 
24 (74%) (Fig. 4A) and X-ray diffraction analysis of tetraol (+)-14. Oxidation of the 
corresponding cyclo-D-Trp-L-Ala derivatives under these conditions resulted only in 
oxidation at the alanine Cα(Ala)-methines, leaving the Cα (D-Trp)-methines unchanged 
(14). This observation, which has important consequences for the choice of natural or 
unnatural amino acid precursors, is attributed to a non-optimal conformation of the C–H 
bond for abstraction and/or the sterically disfavored approach of the oxidant from the 
concave face of the 5,5- ring system.
The dimeric octacyclic tetraol (+)-14 proved highly acid- and base-sensitive. Its treatment 
with BrØnsted acids led to formation of tetraene 26 (Fig. 4B) (22), whereas its exposure to 
base resulted in either decomposition or conversion to hemiaminal diastereomers (14). The 
high sensitivity of tetraol (+)-14 to base may be attributed to reversible ring opening at the 
C15-aminal allowing deleterious side reactions of the alpha-keto amide derivative 27 (Fig. 
4B). Surprisingly, even dissolution of (+)-14 in methanol at ambient temperature led to slow 
decomposition.
With multi-gram access to dimeric octacyclic tetraol (+)-14, we focused on its conversion to 
alkaloid (+)-1. Removal of the benzenesulfonyl groups with sodium amalgam in methanol 
buffered with dibasic sodium phosphate unveiled an unstable diaminotetrahemiaminal 28 
(Fig. 4C). Immediate exposure of this labile compound to condensed hydrogen sulfide at 
−78 °C with a Lewis acid (6), followed by warming, resulted in formation of the 
corresponding tetrathiol 29 as a mixture of hemithioaminal diastereomers. Oxidation of the 
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crude mixture of tetrathiols with potassium triiodide resulted in (+)-11,11'-dideoxyverticillin 
A (1), albeit in low overall yields (2–15%, 3-steps) from tetraol (+)-14.
The fragility of tetraol (+)-14 and derivatives 28 and 29, the poor mass balance of this 
capricious three-step sequence, and our preference to avoid the use of pressurized toxic 
hydrogen sulfide led us to seek a superior strategy for the synthesis of the 
epidithiodiketopiperazine substructure of this family of alkaloids. After substantial 
experimentation we realized that a simple tactical conversion of the tetraol (+)-14 to the diol 
(+)-15 (Fig. 3) imparted considerable stability to this structure, consistent with prevention of 
an undesired diketopiperazine ring-opening. The use of Fu’s PPY-catalyst (5 mol%) (23) 
was optimal for the selective derivatization of both alanine-derived hemiaminals of (+)-14 
(14). Treatment of a methanolic solution of diol (+)-15 containing monobasic sodium 
phosphate with sodium amalgam cleanly unveiled the stable diaminodiol (+)-16 in 87% 
yield as a surrogate for our hypothetical biosynthetic intermediate 6 (Fig. 2).
At this juncture, we envisioned that coordinating the introduction of the two sulfur atoms on 
each diketopiperazine ring would provide greater stereochemical control and structural 
stability. Inspired by the Woodward-Prévost cis-dihydroxylation of alkenes with carboxylate 
ions (24), and cognizant of the observation from Kishi’s seminal synthesis of gliotoxin that 
epidithiodiketopiperazines are acutely sensitive toward basic, reductive, oxidative and 
strongly acidic conditions (5), we reasoned that the use of a trithiocarbonate (25) would 
deliver a sulfurated product poised for mild unveiling of the targeted tetrathiol at an 
advanced stage. In the event, treatment of diaminodiol (+)-16 with potassium 
trithiocarbonate and trifluoroacetic acid in dichloromethane resulted in rapid formation and 
isolation of the desired dimeric bisdithiepanethione (+)-18 in 56% yield (14, 26), likely via 
kinetic trapping of iminium ion 17 followed by intramolecular dithiepanethione formation. 
In this single operation, four carbon–oxygen bonds are exchanged for four carbon–sulfur 
bonds, the stereochemistry at all four tertiary thiols is secured, and the targeted cis-
dithiodiketopiperazine substructure of 5 is attained.
Addition of ethanolamine to a solution of bisdithiepanethione (+)-18 at 23 °C rapidly 
afforded the proposed biosynthetic precursor diaminotetrathiol 5 (27), which is subject to 
mild oxidation to (+)-1 upon exposure to air (14). Under optimized conditions, following the 
formation of diaminotetrathiol 5, partitioning of the reaction mixture between aqueous 
hydrochloric acid and dichloromethane and immediate addition of potassium triiodide to the 
organic layer provided (+)-11,11'-dideoxyverticillin A (1, [α]21D = +590 (c 0.30, CHCl3); 
lit. [α]21D = +624.1 (c 0.3, CHCl3), 1) in 62% yield as a colorless solid. All spectroscopic 
data for (+)-1 matched those reported in the literature (1). Furthermore, we unambiguously 
secured the structure of synthetic (+)-1 by crystallographic analysis.
This concise strategy for the synthesis of (+)-1 required a carefully choreographed sequence 
of events. In this sequence, the inherent chemistry of intermediates was maximally utilized 
in generation of chemical complexity and stereochemical control. For example, unveiling of 
the aniline nitrogen (N1) of (+)-13 followed by attempted tetrahydroxylation led to complete 
decomposition under a variety of conditions. The challenges associated with the high 
sensitivity of (+)-13 toward epimerization at the L-amino acid derived Cα-stereocenters was 
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compounded by the requirement for oxidation prior to epimerization (vide supra). 
Furthermore, thiolation of the oxidized diketopiperazines at an earlier stage led to significant 
reductive cleavage or elimination of the sensitive carbon–sulfur bonds during subsequent 
transformations. These key insights guided our described strategy, whereby the conversion 
of diaminodiol (+)-16 to dimeric dithiepanethione (+)-18 enabled tetrathiolation with 
concomitant inversion of all four Cα-stereocenters, allowing rapid epidithiodiketopiperazine 
formation.
Collectively, our observations on the inherent reactivity of these structures hint at a plausible 
biosynthetic sequence for alkaloid (+)-1 (Fig. 2). While the viability of the proposed 
biosynthetic intermediates is supported through chemical synthesis, the successful 
implementation of our synthetic strategy offers a potential roadmap to the function of 
enzymes involved in the biosynthesis of epidithiodiketopiperazine alkaloids. For instance, 
Howlett’s studies of the epidithiodiketopiperazine biosynthetic gene clusters (28) have 
identified genes with unassigned specific function bearing structural homology to the 
cytochrome P450 mono-oxygenase. The mechanistic semblance of our permanganate 
diketopiperazine hydroxylation to the well studied C–H abstraction–hydroxylation of 
substrates by P450 oxygenases (29–30) prompts consideration of the involvement of these 
unassigned genes in the Cα-oxidation of the diketopiperazine core.
Alkaloid (+)-1 potently inhibits the tyrosine kinase activity of the epidermal growth factor 
receptor (IC50 = 0.14 nM), exhibits antiangiogenic activity, and has efficacy against several 
cancer cell lines (31–33). The strategy and methodologies described here are expected to 
yield ready access to related compounds and provide an inroad to further biological studies. 
In this report we have attempted to capture the power of biosynthetic considerations as a 
guiding principle for synthetic planning and as an inspiration for the development of new 
reactions.
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The molecular structure of (+)-11,11'-dideoxyverticillin A (1) and representative dimeric 
epidithiodiketopiperazine alkaloids.
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Retrosynthetic analysis of (+)-11,11'-dideoxyverticillin A (1) based on a biosynthetic 
hypothesis.
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Concise enantioselective total synthesis of (+)-11,11'-dideoxyverticillin A (1). Isolated 
yields are given for each step. Conditions: (a) trifluoroacetic acid (TFA), dichloromethane 
(CH2Cl2), 23 °C, 4 h; tert-butanol (tBuOH), morpholine, 23 °C, 48 h. (b) Br2, acetonitrile 
(MeCN), 0 °C, 5 min. (c) methyl iodide (MeI), K2CO3, acetone, 23 °C, 5 d. (d) 
tris(triphenylphosphine)cobalt(I) chloride (CoCl(PPh3)3), acetone, 23 °C, 30 min. (e) 
bis(pyridine)silver(I) permanganate (Py2AgMnO4), CH2Cl2, 23 °C, 2 h. (f) tert-
butyl(chloro)dimethylsilane (TBSCl), (R)-(+)-4-
pyrrolidinopyridinyl(pentamethylcyclopentadienyl)-iron (PPY) 5 mol%, triethylamine 
(Et3N), N,N-dimethyl formamide (DMF), 23 °C. (g) 5% Na(Hg), NaH2PO4, methanol 
(MeOH), 23 °C. (h) K2CS3, TFA, CH2Cl2, 28 min. (i) ethanolamine, 23 °C; KI3, pyridine, 
CH2Cl2, 23 °C. The thermal ellipsoid representation of synthetic (+)-1 from X-ray 
crystallographic analysis is shown with most hydrogens omitted for clarity.
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Key observations enabling our first-generation synthesis of (+)-11,11'-dideoxyverticillin A 
(1). A. Functionalization of exploratory models. B. Sensitivity of dimeric octacyclic tetraol 
(+)-14 to both acidic and basic conditions. C. Thermal ellipsoid representation of (+)-14. 
Synthesis of alkaloid (+)-1 from dimeric tetraol (+)-14. Conditions: (a) 5% Na(Hg), 
Na2HPO4, MeOH, 23 °C. (b) H2S, CH2Cl2, hafnium(IV) trifluoromethanesulfonate 
(Hf(OTf)4), –78→23 °C, 14 h. (c) KI3, pyridine, CH2Cl2, 23 °C, 2–15% for 3-steps.
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